標(biāo)題: Titlebook: Biochemical Basis and Therapeutic Implications of Angiogenesis; Jawahar L. Mehta,Pankaj Mathur,Naranjan S. Dhalla Book 2017Latest edition [打印本頁(yè)] 作者: emanate 時(shí)間: 2025-3-21 18:24
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis影響因子(影響力)
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis影響因子(影響力)學(xué)科排名
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis網(wǎng)絡(luò)公開(kāi)度
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis被引頻次
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis被引頻次學(xué)科排名
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis年度引用
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis年度引用學(xué)科排名
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis讀者反饋
書目名稱Biochemical Basis and Therapeutic Implications of Angiogenesis讀者反饋學(xué)科排名
作者: Heart-Rate 時(shí)間: 2025-3-21 23:51 作者: Glucocorticoids 時(shí)間: 2025-3-22 01:08 作者: 平靜生活 時(shí)間: 2025-3-22 06:31
Functions of MicroRNAs in Angiogenesis, apoptosis, and tissue inflammation. There are more than 1, 000 miRs in human genome, some of them are involved in angiogenesis. In this review, we will summarize the recent progress on function of miRs in angiogenesis.作者: Atheroma 時(shí)間: 2025-3-22 10:10
Therapeutic Implications of Angiogenesis in Cancerpensive treatments and those likely to suffer severe toxicity. Hence, the complexity of the task and the need to embed the study of these markers in the design of phase III randomized controlled trials.作者: Celiac-Plexus 時(shí)間: 2025-3-22 15:09 作者: TRAWL 時(shí)間: 2025-3-22 19:26
Book 2017Latest editioncer, angiogenesis’ role in atherosclerosis and heart disease as well as metabolic disorders and?peripheral vascular disease. The book is comprehensive in its coverage?of angiogenesis in a diverse set of diseases and examines the role of cellular and subcellular structures during the development of a作者: CHOP 時(shí)間: 2025-3-22 23:19 作者: 共棲 時(shí)間: 2025-3-23 02:36
Mast Cells in Angiogenesis: The Role of Angiogenic Cytokinesetin-1 (Ang-1). In this context, mast cells might act as a new target for the adjuvant treatment of tumors through the elective inhibition of angiogenesis. Preclinical studies in experimental models using anti-cKit antibodies, or the mast cell stabilizer disodium cromoglycate have shown promising results.作者: 歡騰 時(shí)間: 2025-3-23 07:52
2512-2142 e role of angiogenesis in atherosclerosis and heart disease,.This book covers the latest developments in the therapeutic implications of angiogenesis, ranging from angiogenesis in the brain, angiogenesis in cancer, angiogenesis’ role in atherosclerosis and heart disease as well as metabolic disorder作者: 開(kāi)玩笑 時(shí)間: 2025-3-23 13:14 作者: 可耕種 時(shí)間: 2025-3-23 16:21
https://doi.org/10.1007/978-3-531-90090-2etin-1 (Ang-1). In this context, mast cells might act as a new target for the adjuvant treatment of tumors through the elective inhibition of angiogenesis. Preclinical studies in experimental models using anti-cKit antibodies, or the mast cell stabilizer disodium cromoglycate have shown promising results.作者: paltry 時(shí)間: 2025-3-23 18:14
https://doi.org/10.1007/978-3-658-06534-8were correlated in previous studies with increased tumor VEGF expression, vascular density and poor survival. However, anti-angiogenic drugs did not show to be cost-effectiveness in NSCLC. This topic will address research involving angiogenesis genetic polymorphisms and NSCLC behavior.作者: 殘酷的地方 時(shí)間: 2025-3-24 01:15 作者: 克制 時(shí)間: 2025-3-24 03:07
The Role of Angiogenesis in Non-small Cell Lung Cancer Tumor Behaviorwere correlated in previous studies with increased tumor VEGF expression, vascular density and poor survival. However, anti-angiogenic drugs did not show to be cost-effectiveness in NSCLC. This topic will address research involving angiogenesis genetic polymorphisms and NSCLC behavior.作者: 緩和 時(shí)間: 2025-3-24 08:07 作者: Acupressure 時(shí)間: 2025-3-24 13:45 作者: motivate 時(shí)間: 2025-3-24 15:14
Jawahar L. Mehta,Pankaj Mathur,Naranjan S. DhallaCovers the basics of the physiology of angiogenesis, including VEGF pathways in angiogenesis, integrins in angiogenesis, and more.Details the role of angiogenesis in atherosclerosis and heart disease,作者: Afflict 時(shí)間: 2025-3-24 22:53
Advances in Biochemistry in Health and Diseasehttp://image.papertrans.cn/b/image/186552.jpg作者: ELUDE 時(shí)間: 2025-3-25 01:14 作者: capsaicin 時(shí)間: 2025-3-25 04:13
978-3-319-87008-3Springer International Publishing AG 2017作者: Juvenile 時(shí)間: 2025-3-25 11:01 作者: MOCK 時(shí)間: 2025-3-25 15:13 作者: 兩種語(yǔ)言 時(shí)間: 2025-3-25 19:23 作者: 船員 時(shí)間: 2025-3-25 20:10
Journalismus und Medien als Organisationenularization process. Disruption or dysregulation of angiogenesis is involved in various pathological conditions, such as ischemia and tumor progression. Stimulation of angiogenesis was proposed to be able to restore the blood flow and contribute to the tissue recovery in ischemia, while inhibition o作者: 青少年 時(shí)間: 2025-3-26 01:02
https://doi.org/10.1007/978-3-531-90090-2able for development and homeostasis of the vascular system. TGFβ drives vascular responses via its binding to a TGFβ receptor complex formed by type I and type II receptors, as well a type III co-receptors present on both endothelial and mural cells. Signaling by these receptors is context dependen作者: TRACE 時(shí)間: 2025-3-26 07:32
Journalismus und Medien als Organisationen activities in epithelial cells through tyrosine phosphorylation of its receptor, c-Met. HGF-c-Met axis is necessary for embryogenesis, organogenesis and tissue repair of almost epithelial organs. Indeed, a loss in HGF-c-Met signaling pathways leads to organ damage and dysfunction during acute and c作者: Flat-Feet 時(shí)間: 2025-3-26 12:05 作者: Priapism 時(shí)間: 2025-3-26 13:14 作者: BLUSH 時(shí)間: 2025-3-26 17:46 作者: 燦爛 時(shí)間: 2025-3-27 00:59 作者: Compassionate 時(shí)間: 2025-3-27 01:54 作者: Insul島 時(shí)間: 2025-3-27 05:59 作者: precede 時(shí)間: 2025-3-27 12:50
Journalismus und Public Relationsand proliferative diabetic retinopathy (PDR). Inflammation and ischemia, which result from hyperglycemia-induced oxidative stress, are primary drivers of diabetic retinopathy and vision loss. Several chemokines and cytokines are upregulated in eyes with diabetic retinopathy, and vascular endothelial作者: Saline 時(shí)間: 2025-3-27 14:14
Journalismus und Public Relations supplies blood to the lower extremities is interrupted and blood flow to the distal limb becomes dependent on the presence, extent, and function of collateral blood vessels. Estimates are PAD is present in ~8.5 million Americans at or over the age of 40 and the two major clinical manifestations of 作者: Magnificent 時(shí)間: 2025-3-27 19:08 作者: Cabinet 時(shí)間: 2025-3-28 01:15
Endothelial Growth Factor Receptors in Angiogenesisdevelopment in embryos and angiogenesis in adults. As the signaling of these tyrosine kinase receptors has been elucidated, we have gained an appreciation of the complex interactions with other receptors, co-receptors, and downstream pathways..Its involvement in pathology makes it a particularly tem作者: infelicitous 時(shí)間: 2025-3-28 06:08 作者: negotiable 時(shí)間: 2025-3-28 07:14
Toll-Like Receptors in Angiogenesisssociated molecular patterns (PAMPs) of microbial and viral origin bind to TLRs and initiate the innate and adaptive immune response. However, TLRs are not solely found on cells of the immune system but also on non-myeloid cells in various tissues, e.g., on vascular cells. In addition to PAMPs, ther作者: Little 時(shí)間: 2025-3-28 11:40 作者: blister 時(shí)間: 2025-3-28 14:59
Role of Transforming Growth Factor Beta Family in Angiogenesisable for development and homeostasis of the vascular system. TGFβ drives vascular responses via its binding to a TGFβ receptor complex formed by type I and type II receptors, as well a type III co-receptors present on both endothelial and mural cells. Signaling by these receptors is context dependen作者: CHURL 時(shí)間: 2025-3-28 21:35
Angiogenesis-Based Strategy by Hepatocyte Growth Factor for the Treatment of Ischemic Organ Diseases activities in epithelial cells through tyrosine phosphorylation of its receptor, c-Met. HGF-c-Met axis is necessary for embryogenesis, organogenesis and tissue repair of almost epithelial organs. Indeed, a loss in HGF-c-Met signaling pathways leads to organ damage and dysfunction during acute and c作者: 精致 時(shí)間: 2025-3-29 00:03 作者: athlete’s-foot 時(shí)間: 2025-3-29 05:32
Mast Cells in Angiogenesis: The Role of Angiogenic Cytokinesin this process is mostly certain related to the release of a large spectrum of angiogenic cytokines, including vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), transforming growth factor beta (TGFβ), tumor necrosis factor alpha (TNFα), interleukin-8 (IL-8) and angiopoi作者: 出汗 時(shí)間: 2025-3-29 07:24
Therapeutic Implications of Angiogenesis in Cancero become cancer-disease without activating angiogenesis. This chapter addresses the factors involved in tumor angiogenesis and the progress made to exploit this phenomenon. Tumors are very heterogeneous in their angiogenic pathways and drugs targeting angiogenesis are moderately effective in the met作者: 高度 時(shí)間: 2025-3-29 14:54 作者: 火海 時(shí)間: 2025-3-29 18:08
Angiogenesis and Prostate Cancer: Friends or Foes) that can help investigators to design specific anti-angiogenic strategies, it is reasonable to assume that the quantification of various aspects of tumor vasculature may provide an indication of angiogenic activity. It has been ascertained that malignant tumors can generate their vasculature in se作者: Lipoprotein(A) 時(shí)間: 2025-3-29 20:55 作者: 出來(lái) 時(shí)間: 2025-3-30 02:38 作者: enfeeble 時(shí)間: 2025-3-30 07:09 作者: 許可 時(shí)間: 2025-3-30 09:23
Cell-Based Therapy in Ischemic Heart Diseaseincreasing socioeconomic burden. A solid body of evidence has previously indicated a regenerative capacity of stem and progenitor cell-based therapy in preclinical and early-phase clinical studies. Clinical application of stem and progenitor cells in ischemic heart disease have included patients wit
